Drug Enforcement Act

Drug Enforcement Act

Relevant to real estate as it allows seizure of real property if illegal drug activities take place on it. Innocent owners may successfully contest the seizure after expending large sums of money to lawyers to prove that the owner had no involvement and no knowledge of the drug activity or took steps to stop the illegal activity but was unsuccessful. (The lesson for property owners is that if you are suspicious about drug-related activity in your apartments or other properties,you cannot take a “live and let live”approach to the problem.)

References in periodicals archive ?
After media reports indicated that the Ensuring Patient Access and Effective Drug Enforcement Act of 2016 had dramatically restricted DEAs ability to crack down on opioid distributors suspected of wrongdoing, McCaskill introduced a bill to repeal the law, and she led a Senate roundtable on her bill.
Marino introduced three versions of the Ensuring Patient Access and Effective Drug Enforcement Act between 2014 and 2015 before H.R.
That is why we are pleased that the Ensuring Patient Access and Drug Enforcement Act (Public Law 114-145) includes an opportunity for federal agencies, led by the Department of Health and Human Services (HHS), and supply chain stakeholders to work together on an interagency report to Congress.
December 21, 2017: Senator Manchin sent a letter to Attorney General Jeff Sessions and Acting Administrator Robert Patterson regarding the Ensuring Patient Access and Effective Drug Enforcement Act that was signed into law that significantly stripped the DEAs authority to stop unlawful distribution of opioids.
He referenced two recent bipartisan and NACDS-backed pieces of legislation signed into law by the president this year: the Ensuring Patient Access and Drug Enforcement Act and the Comprehensive Addiction and Recovery Act.
McCaskill has introduced a bill repealing the Ensuring Patient Access and Effective Drug Enforcement Act of 2016 after media reports indicated that it had dramatically restricted the ability of the Drug Enforcement Administration to crack down on opioid distributors suspected of wrongdoing.
"Following two significant legislative victories [the Drug Supply Chain Security Act (DSCSA) and the Ensuring Patient Access and Effective Drug Enforcement Act of 2016 (S.
The trade organization backs the Ensuring Patient Access and Effective Drug Enforcement Act of 2016 (S.
McCaskill recently introduced a bill repealing the Ensuring Patient Access and Effective Drug Enforcement Act of 2016 after media reports indicated that it had dramatically restricted the ability of the Drug Enforcement Administration (DEA) to crack down on opioid distributors suspected of wrongdoing.
-- The Senate has passed the Ensuring Patient Access and Effective Drug Enforcement Act of 2016 (S.
The letter follows a Washington Post/60 Minutes investigation into the impact of the Ensuring Patient Access and Effective Drug Enforcement Act on DEAs ability to combat opioid addiction, and subsequent testimony from DEA officials that the law needs to be changed.
The trade organization supports the Ensuring Patient Access and Effective Drug Enforcement Act of 2016 (S.
Full browser ?